The insulin tolerance test in morbidly obese patients undergoing bariatric surgery (Q43822500)

27 November 2017

The insulin tolerance test in morbidly obese patients undergoing bariatric surgery (English)

1 reference

27 November 2017

0 references

0 references

1 reference

Geloneze B

1

1 reference

27 November 2017

Tambascia MA

2

1 reference

27 November 2017

Pareja JC

3

1 reference

27 November 2017

Repetto EM

4

1 reference

27 November 2017

Magna LA

5

1 reference

27 November 2017

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

9

1 reference

27 November 2017

12

1 reference

27 November 2017

763-769

1 reference

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

27 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Surgical intervention for the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Update: NIH consensus conference. Gastrointestinal surgery for severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Does gastric restriction surgery reduce the risks of metabolic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

The Short Insulin Tolerance Test for Determination of Insulin Sensitivity: A Comparison with the Euglycaemic Clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Is the short insulin tolerance test safe and reproducible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

The prevention and treatment of obesity. Application to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

The intravenous insulin tolerance test is an accurate method for screening a general population for insulin resistance and related abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Body composition and surgical treatment of obesity. Effects of weight loss on fluid distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Body composition and source of weight loss after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

The treatment of obesity in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Treatment of diabetes in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

A comparison of fat intake of normal weight, moderately obese and severely obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Differentiated long-term effects of intentional weight loss on diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Morbid obesity and related health risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Mortality of severely obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

"Morbid" obesity: a hazardous disorder that resists conservative treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Gastric restriction procedures for treating severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Changes in Diabetic Management After Roux-en-Y Gastric Bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Reducing early technical complications in gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Surgical treatment for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Performance standards in bariatric surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

Increased extracellular water compartment, relative to intracellular water compartment, after weight reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.105

31 March 2020

Identifiers

DOI

10.1038/OBY.2001.105

1 reference

27 November 2017

1 reference